iPLATO Scales Indicative At-home Blood Pressure Checking to 3 Million myGP Users with Lifelight

Today, DigitalHealth.London Accelerator alumni companies Huma and Lifelight announce their partnership scaling indicative at-home Blood Pressure Checking through iPLATO (part of Huma) to 3 million users across the UK via the myGP app.

Hypertension affects 12 million people in the UK and is the leading cause of cardiovascular disease (CVD), while CVD is still the leading cause of death globally (WHO). Figures from the British Heart Foundation estimate that as many as 5 million adults in the UK alone could be living with undiagnosed high blood pressure (hypertension).

With only approx. 30% of diagnosed hypertensives self-checking their blood pressure at home, the myGP app bolstered with Lifelight wants to change this picture – finding the “unreached” – those with undiagnosed hypertension and make it easy for everyone to check their blood pressure.

In an exciting next step for digital healthcare, iPLATO – part of Huma – has partnered with Lifelight, a cutting-edge novel technology to bring convenient blood pressure checking to 3 million users of the myGP app.

Since integrating Lifelight into myGP at the end of November last year, usage has been growing fast, including many repeat users returning to the app to check their blood pressure, demonstrating trust in Lifelight and its ease of use.

Currently available to iOS myGP users, given the strong uptake to date, Lifelight will shortly be made available to Android users, further increasing usage and empowering more people who want to take responsibility for their health.

Lifelight provides the ability for myGP users to easily check their blood pressure themselves at home, with on-screen instructions to guide them. As well as providing fast vital signs readings, one of the key benefits of Lifelight is the user experience – zero contact – no uncomfortable cuff, no need to undress and no wearables – users simply look at their smartphone screen for 40 seconds.

Often more convenient, myGP’s existing 3 million users can access Lifelight securely from the comfort of their homes. This is where Lifelight can scale, driving efficiencies with improved health outcomes, saving more lives and addressing healthcare inequalities by reaching more people at risk of CVD early and providing access to the right care pathway.

Supporting goals outlined in the NHS Long Term Plan, the collaboration harnesses digital innovation to enhance preventive care and early detection of health conditions, aligning with the plan’s focus on a digitally-enabled healthcare system.

We recognise how much this partnership can help our users to easily track their blood
pressure. Integrating Lifelight’s capabilities into the myGP app not only makes blood pressure checking convenient but also supports our commitment to empowering users to manage their health effectively.

Tobias Alpsten
CEO and Founder of myGP

The cost to the NHS of high blood pressure is estimated at over £2bn every year. However, high blood pressure is preventable, and for those with high blood pressure a reduction of just 10mmHg can significantly reduce their risk of a heart attack or stroke. This means identifying, diagnosing and managing hypertension is more vital now than ever, which Lifelight can support via a user’s own smartphone. We’re driven by the success and acceptance of myGP users, allowing us to scale Lifelight and look forward to reaching more people as usage increases, enabling us to support as many people as possible to effectively manage their blood pressure.

Laurence Pearce
CEO and Founder of Lifelight

Find out more at iPLATO scales at home Blood Pressure checking to 3m myGP users with Lifelight – Lifelight.

Huma and Lifelight are alumni companies of the DigitalHealth.London Accelerator programme.

The DigitalHealth.London Accelerator programme is funded by the UK Government via the UK Shared Prosperity Fund (UKSPF). It is delivered by the Health Innovation Network (HIN) South London in partnership with the Office of Life Sciences, CW+, Medicity, NHS England, the Mayor of London and the Levelling Up Fund.

For more information, please visit https://www.gov.uk/government/publications/uk-